Researchers have found that combining tolerogenic dendritic cells with Dimethyl Fumarate improves treatment efficacy for ...

Multiple sclerosis (MS) is a long-term disease where the immune system mistakenly attacks the protective layer around nerve ...

A sublingual formulation of cladribine showed comparable pharmacological properties to its name brand counterpart, Mavenclad.

Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown ...

Are autoimmune diseases fatal? Normally, your immune system fights off disease and protects your body from infection. However, when you have an autoimmune disease, your immune system ...

Researchers have now ... Treatment at the First Signs of MS Could Mean Lower Risk of Disability Later July 19, 2023 — People who start taking medication soon after the first signs of multiple ...

It took GLP-1 medications like Ozempic just seven years to surpass insulin as the the second most common treatment for type 2 ...

Even if you have primary progressive multiple sclerosis (PPMS), which is expected to worsen over time, there is a lot your doctor can do to minimize it. Researching about the latest treatments can ...

Evidence is rising in favor of using highly effective DMTs to treat pediatric MS, but with few licensed for pediatric use, it ...

New treatments for promoting nerve cells regrowth in people with MS are inviting optimism at the University of Saskatchewan.

In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before ...

Unjustified fears about harm in pregnancy is preventing the use of highly effective medications in women with MS, new ...